HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Z Berneman Selected Research

CHVP protocol

4/2008Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Z Berneman Research Topics

Disease

2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2006 - 10/2005
2Angiomatosis
12/2003 - 12/2003
2Thrombocytosis (Thrombocythemia)
03/2003 - 12/2002
2Hypothyroidism
06/2001 - 04/2001
2Wilms Tumor (Wilm's Tumor)
06/2001 - 04/2001
1Schistosomiasis mansoni
11/2015
1Trematode Infections (Fasciolopsiasis)
11/2015
1Primary Myelofibrosis (Myelosclerosis)
04/2015
1Splenomegaly
04/2015
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2008
1Pathologic Complete Response
10/2006
1Leukemia
10/2005
1Neoplasms (Cancer)
10/2005
1Venous Thrombosis (Deep-Vein Thrombosis)
02/2005
1Polycythemia Vera
03/2003
1Pain (Aches)
03/2003
1Thrombosis (Thrombus)
12/2002
1Ischemia
12/2002
1Thrombocytopenia (Thrombopenia)
12/2002
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
12/2002
1Pancytopenia
01/2002
1Vitamin B 12 Deficiency (Vitamin B12 Deficiency)
01/2002
1Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2001
1Monoclonal Gammopathy of Undetermined Significance
06/2001
1Multiple Myeloma
06/2001
1Myeloproliferative Disorders (Myeloproliferative Disorder)
06/2001
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2001
1Hemorrhage
04/2001
1Disease Susceptibility (Diathesis)
04/2001
1Autoimmune Diseases (Autoimmune Disease)
04/2001

Drug/Important Bio-Agent (IBA)

3AntigensIBA
11/2015 - 04/2001
2Prednisone (Sone)FDA LinkGeneric
04/2008 - 04/2001
2Proteins (Proteins, Gene)FDA Link
06/2001 - 04/2001
2von Willebrand FactorIBA
06/2001 - 04/2001
2Thyroxine (Levothyroxine)FDA LinkGeneric
06/2001 - 04/2001
2Factor VIII (Coagulation Factor VIII)IBA
06/2001 - 04/2001
2Hyaluronic Acid (Hyaluronan)IBA
06/2001 - 04/2001
1Hemoglobins (Hemoglobin)IBA
04/2015
1Vincristine (Oncovin)FDA LinkGeneric
04/2008
1Bleomycin (Blenoxane)FDA LinkGeneric
04/2008
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2008
1Teniposide (VM 26)FDA Link
04/2008
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2008
1Vindesine (Vindesin)IBA
04/2008
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2006
1Etoposide (VP 16)FDA LinkGeneric
10/2006
1IceIBA
10/2006
1Mitoxantrone (Novantrone)FDA LinkGeneric
10/2006
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
10/2006
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2006
1Gemtuzumab (Mylotarg)FDA Link
10/2005
1cupric sulfide (CuS)IBA
02/2005
1fibrin fragment D (D-dimer)IBA
02/2005
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2003
1AnticoagulantsIBA
03/2003
1Heparin (Liquaemin)FDA LinkGeneric
12/2002
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2002
1Intrinsic FactorFDA Link
01/2002
1ParaproteinsIBA
06/2001
1Prednisolone (Predate)FDA LinkGeneric
06/2001
1Immunoglobulin G (IgG)IBA
06/2001
1RistocetinIBA
06/2001
1Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
06/2001
1CollagenIBA
06/2001
1CoagulantsIBA
06/2001
1AutoantibodiesIBA
06/2001
1Intravenous Immunoglobulins (IVIG)FDA Link
06/2001
1Factor VII (Proconvertin)IBA
04/2001
1Blood Coagulation Factors (Coagulation Factor)IBA
04/2001

Therapy/Procedure

4Drug Therapy (Chemotherapy)
04/2008 - 04/2001
3Therapeutics
11/2015 - 03/2003
2Splenectomy
12/2003 - 12/2003
2Aftercare (After-Treatment)
06/2001 - 04/2001
1Radiotherapy
04/2015
1CHVP protocol
04/2008
1Consolidation Chemotherapy
10/2006
1Induction Chemotherapy
10/2006
1Bloodletting
03/2003